Global Lung Cancer Surgery Market Growth (Status and Outlook) 2023-2029

Global Lung Cancer Surgery Market Growth (Status and Outlook) 2023-2029

Lung adenocarcinoma is a type of lung cancer and belongs to non-small cell carcinoma.

LPI (LP Information)' newest research report, the “Lung Cancer Surgery Industry Forecast” looks at past sales and reviews total world Lung Cancer Surgery sales in 2022, providing a comprehensive analysis by region and market sector of projected Lung Cancer Surgery sales for 2023 through 2029. With Lung Cancer Surgery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lung Cancer Surgery industry.

This Insight Report provides a comprehensive analysis of the global Lung Cancer Surgery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lung Cancer Surgery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lung Cancer Surgery market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lung Cancer Surgery and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lung Cancer Surgery.

The global Lung Cancer Surgery market size is projected to grow from US$ 19780 million in 2022 to US$ 28980 million in 2029; it is expected to grow at a CAGR of 5.6% from 2023 to 2029.

North America dominates the global lung cancer surgery market. Growth in the North American segment is primarily driven by the rapid growth in the aging population, availability of reimbursement for lung cancer surgeries, and increasing incidence of lung cancer.

This report presents a comprehensive overview, market shares, and growth opportunities of Lung Cancer Surgery market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Surgical Instruments
Monitoring And Visualization System

Segmentation by application
Lobectomy
Removal Of Sleeve
Regional Excision
Lung Removed All
Minimally Invasive Surgery

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Accuray
Angiodynamics
Ethicon
Intuitive Surgical
Olympus
Teleflex
Ackermann Instrumente
Karl Storz
Scanlan International
Trokamed

Please note: The report will take approximately 2 business days to prepare and deliver.